| STREP/STIP Activity type |
CODA |
IHA |
CIDC-Lelystad |
DVI |
BFAV Riems |
total (2 tables combined) |
| Research/innovation
activities |
|
|
|
|
|
|
| WP1. Validation of existing NSP-tests. |
6 |
6 |
11 |
6 |
8 |
58 |
| WP2. Development and validation
of confirmatory and new NSP-tests. |
|
4 |
|
18 |
8 |
153.5 |
| WP3. Improved FMD virus detection. |
36 |
|
10 |
|
8 |
54 |
| WP4. Impact of vaccination on
virus dissemination and the carrier state. |
|
76 |
16 |
|
|
92 |
| WP5. Improved vaccine strain
selection. |
36 |
4 |
10 |
36 |
40 |
193 |
| WP6. Development of a new marker
vaccine. |
|
50 |
|
|
|
146 |
| Total research/innovation |
78 |
140 |
47 |
60 |
64 |
696.5 |
| Management activities |
|
|
|
|
|
|
| WP1. Project Management |
6 |
2 |
2 |
2 |
2 |
24 |
| Total management |
6 |
2 |
2 |
2 |
2 |
24 |
| TOTAL per Participant |
84 |
142 |
49 |
62 |
66 |
|